.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The MAGIC trial was one of the landmark studies that changed the management of resectable gastroesophageal cancer. It compared surgery alone with perioperative chemotherapy followed by surgery and postoperative chemotherapy in patients with operable gastric and lower esophageal cancers. Patients receiving perioperative chemotherapy had improved progression-free and overall survival compared with surgery alone. The study demonstrated why systemic treatment should not necessarily be deferred until after an operation: chemotherapy can treat occult disease early, potentially shrink the primary tumor and improve the chances of completing planned multimodality therapy. Although modern regimens and staging have evolved, the trial established the principle that surgery should be integrated into a broader oncological strategy rather than considered an isolated intervention. For contemporary practice, it also reinforces the importance of multidisciplinary planning before surgery, because nutritional status, staging, resectability, medical fitness and postoperative treatment all influence the final pathway. The results underpin the continued use of perioperative chemotherapy strategies in appropriately selected resectable gastroesophageal cancers.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The MAGIC trial was one of the landmark studies that changed the management of resectable gastroesophageal cancer. It compared surgery alone with perioperative chemotherapy followed by surgery and postoperative chemotherapy in patients with operable gastric and lower esophageal cancers. Patients receiving perioperative chemotherapy had improved progression-free and overall survival compared with surgery alone. The study demonstrated why systemic treatment should not necessarily be deferred until after an operation: chemotherapy can treat occult disease early, potentially shrink the primary tumor and improve the chances of completing planned multimodality therapy. Although modern regimens and staging have evolved, the trial established the principle that surgery should be integrated into a broader oncological strategy rather than considered an isolated intervention. For contemporary practice, it also reinforces the importance of multidisciplinary planning before surgery, because nutritional status, staging, resectability, medical fitness and postoperative treatment all influence the final pathway. The results underpin the continued use of perioperative chemotherapy strategies in appropriately selected resectable gastroesophageal cancers.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
3 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
4 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
